Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes

Acta Oncologica

Volumn 54, Issue 6, 2015, Pages 875-881

  Lennernäs, Bo ^b   Majumder, Khairul ^a   Damber, Jan Erik ^b   Albertsson, Per ^b   Holmberg, Erik ^c   Brandberg, Yvonne ^a   Isacsson, Ulf ^d   Ljung, Gunilla ^e   Damm, Ole ^f   Nilsson, Sten ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e Mälar Hospital   (Sweden)

^f LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; GONADORELIN DERIVATIVE; LEUPRORELIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FINANCIAL MANAGEMENT; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SOCIAL INTERACTION; SURVIVAL RATE; TREATMENT OUTCOME; ADVERSE EFFECTS; BRACHYTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; COST OF ILLNESS; EMOTION; ERECTILE DYSFUNCTION; FECAL INCONTINENCE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; QUESTIONNAIRE; SOCIAL PARTICIPATION; SWEDEN; URINARY INCONTINENCE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; COST OF ILLNESS; EMOTIONS; ERECTILE DYSFUNCTION; FECAL INCONTINENCE; FLUTAMIDE; HUMANS; LEUPROLIDE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; SOCIAL PARTICIPATION; SURVEYS AND QUESTIONNAIRES; SURVIVAL RATE; SWEDEN; URINARY INCONTINENCE;

EID: 84929314327     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.974827     Document Type: Article

References (17)

1. Cancer incidence of Sweden, Centre for Epidemiology. National Board of Health and Welfare: Stockholm 2009
2. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J,.et al. Comparative analysis of prostate-specifi c antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the prostate cancer Results Study Group. Br J Urol Int 2012: 109; s1
3. Albertsen P C, Hanley J A, Fine J. 2 0-year outcomes following conservative management of clinically localised prostate cancer. JAMA 2005; 293: 2095-101
4. Jane JA, Hamdy F C, Martin RM, Turner E L, Neal D E, Donovan JL. Latest results from the UK trials evaluating prostate cancer screening and treatment: CAP and Protec T studies. Eur J Cancer 2010; 46: 3095-10
5. Bria E, Cuppone F, Giannarelli D, Milella M, Ruggeri EM, Sperduti I,.et al. Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?. Cancer 2009; 115: 3446-56
6. Shelley MD, Kumar S, Wilt T, Staffurth J, Coles B, Mason MD. A systematic review and meta-analysis of randomized trials of neo-adjuvant hormone therapy for localized and locally advanced prostate carcinoma. Cancer Treat Rev 2009; 35: 9-17
7. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P,.et al. Endocrine treatment with or without radiotherapy in locally advanced prostate cancer (SPCG-7/ SFUO-3): An open randomized phase III trial. Lancet 2009; 373: 301-8
8. Jo Y, Junichi H, Tomohiro F, Yoshinari I, Masato F. R adical prostatectomy versus high-dose rate brachytherapy for prostate cancer: Effects on health-related quality of life. Br J Urol Int 2005; 96: 43-7
9. Grenabo L, Grundtman S, Hedelin H. L aparoscopic obturator lymph node dissection in patients with prostate cancer. Scand J Urol Nephrol 1995; 29: 51-5
10. Walsh PC, Mostwin JL. R adical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol 1984; 56; 694-7
11. Aaronson NK, Ahmedzai S, Bergman B. T he European Organization for Research and Treatment of cancer QLQ C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76
12. Fayers P. E ORTC QLQ-C30 scoring manual, 3rd ed. Brussels: EORTC; 2001
13. Paulson D F. R andomized series of treatment with surgery versus radiation for prostate adenocarcinoma. NCI Mono 1988;( 7): 127-31
14. Paulson DF, Lin GH, Hinshaw W, Stephani S. R adical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 1982; 128: 502-4
15. Aus G, Abrahamsson P A, Ahlgren G, Hugosson J, Lundberg S, Schain M,.et al. Hormonal treatment before radical prostatectomy: A 3-year follow-up. J Urol 1998; 159: 2013-6; Discussion 2016-7
16. Wahlgren T, Nilsson S, Ryberg M, Lennern äs B, Brandberg Y. Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: A prospective assessment of acute and late treatment toxicity. Acta Oncol 2005; 44: 633-43
17. Wahlgren T, Brandberg Y, Hä g garth L, Hellstr öm M, Nilsson S. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192) ir brachytherapy: A prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25. Int J Radiat Oncol Biol Phys 2004; 60: 51-9